Hong Kong stock exchange’s new regime permitting companies with dual-class shares to list came into effect on April 30. We asked four experts about the pros and cons of this change.
The city's exchange operator will accept applications from pre-revenue biotech companies and issuers with dual-class shares from next Monday, despite lingering concerns.
AsianInvestor reveals the winning custodians, index provider, law firm, auditor and compliance adviser in the latest batch of its annual Asset Management awards.
Transparency rules can be a useful way to empower investors, but more does not always mean better. It's all about getting the right balance.
Analysts believe China's insurance regulator's scoring of how well insurers manage their assets and liabilities could prove costly for some, but should improve the industry's health.
Anbang’s fall should serve as a serious warning for other Chinese insurers looking to take advantage of insurance sales to help fund asset acquisitions.
Chinese insurer's downfall serves as a reminder not to flout regulators' wishes, but it also reveals a lot about Beijing's attitude towards corporates it deems too important to fall.
Mifid II could squeeze out marginal discretionary portfolio management platforms, but it is unlikely to affect all wealth firms equally, say market experts.
While no wrong-doings were revealed in the recent data leak, wealth clients will have to get used to the increasing demand for transparency, experts said.
A new package of European fund rules won't apply to Asian companies per se, but compliance may be a commercial imperative, writes Paul Moloney of Eversheds Sutherland.
The Singapore regulator's banning of two more individuals for breaches related to the 1MDB scandal could foreshadow more industry closures.
Client on-boarding times are getting significantly longer to the growing frustration of private bank clients, a Hong Kong survey of wealth management firms shows.